Literature DB >> 6346049

Gonadotropin-releasing hormone binding to rat anterior pituitary membrane homogenates. Comparison of antagonists and agonists using radiolabeled antagonist and agonist.

M H Perrin, Y Haas, J E Rivier, W W Vale.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6346049

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  6 in total

1.  Antagonists of luteinizing hormone releasing hormone bind to rat mast cells and induce histamine release.

Authors:  K Sundaram; A Didolkar; R Thau; M Chaudhuri; F Schmidt
Journal:  Agents Actions       Date:  1988-12

2.  Novel ligands for the affinity labelling of luteinizing hormone releasing hormone receptors.

Authors:  S A Ogier; R Mitchell; C M Bladon
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

3.  Highly potent analogues of luteinizing hormone-releasing hormone containing D-phenylalanine nitrogen mustard in position 6.

Authors:  S Bajusz; T Janaky; V J Csernus; L Bokser; M Fekete; G Srkalovic; T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Evaluation of binding of cytotoxic analogs of luteinizing hormone-releasing hormone to human breast cancer and mouse MXT mammary tumor.

Authors:  S R Milovanovic; S Radulovic; A V Schally
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects.

Authors:  S Bajusz; M Kovacs; M Gazdag; L Bokser; T Karashima; V J Csernus; T Janaky; J Guoth; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Effect of treatment with LHRH analogs containing cytotoxic radicals on the binding characteristics of receptors for luteinizing-hormone-releasing hormone in MXT mouse mammary carcinoma.

Authors:  S R Milovanovic; E Monje; K Szepeshazi; S Radulovic; A Schally
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.